900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
humant immunglobulin G 10 g, pulver till injektionsvätska, flaska	Product containing only human immunoglobulin G (medicinal product)
humant immunglobulin G 16 %, injektionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug)
humant immunglobulin G 2,5 g, pulver till injektionsvätska, flaska	Product containing only human immunoglobulin G (medicinal product)
humant immunglobulin G 20 g, injektionsvätska, lösning, flaska	Product containing only human immunoglobulin G (medicinal product)
humant immunglobulin G 5 g, pulver till injektionsvätska, flaska	Product containing only human immunoglobulin G (medicinal product)
humant insulin, 1 mg enhetsdos, blisterförpackning, pulver för inhalation	Human insulin-containing product
humant insulin, 3 mg enhetsdos, blisterförpackning, pulver för inhalation	Human insulin-containing product
humant interferon gamma-1b 200 mikrogram/ml injektionsvätska, lösning, flaska 0,5 ml	Interferon gamma-1b 200 microgram/mL solution for injection
biverkning av humant interferon gamma-1b	Adverse reaction to interferon gamma-1b
humant A 3101-leukocytantigen föreligger	Human leukocyte antigen A*31:01 positive (finding)
humant B 1502-leukocytantigen föreligger	Human leukocyte antigen B*15:02 positive (finding)
humant B 5701-leukocytantigen föreligger	HLA-B*57:01 positive
Human menopausal gonadotrophins 150iu injection	Human menopausal gonadotropin only product
Human menopausal gonadotrophins 150iu injection	Human menopausal gonadotropin only product
humana menopausala gonadotropiner 150 enheter (FSH), pulver för beredning av injektionsvätska, + spädningsvätska	Human menopausal gonadotropin only product
Human menopausal gonadotrophins 75iu injection	Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial
Human menopausal gonadotrophins 75iu injection	Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial
humana menopausala gonadotropiner, 75 enheter (FSH), pulver och vätska till injektionslösning, flaska	Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial
humant normalt immunglobulin 10 g, pulver till intravenös infusion	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 10 g, pulver och vätska till intravenös infusion, lösning	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 10 g, injektionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug)
humant normalt immunglobulin 12 g, injektionsvätska, lösning, flaska	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 16 %, injektionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug)
humant normalt immunglobulin 1 g, infusionsvätska, lösning, flaska	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 2,5 g, pulver till intravenös infusion	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 2,5 g, pulver och vätska till intravenös infusion, lösning	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 2,5 g, infusionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug)
humant normalt immunglobulin 250 mg, injektionsvätska, lösning, flaska	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 3 g, infusionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
humant normalt immunglobulin 500 mg, pulver till intravenös infusion	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 500 mg, pulver och vätska till intravenös infusion, lösning	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 500 mg, infusionsvätska, lösning, flaska	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 5 g, pulver till intravenös infusion	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 5 g, pulver och vätska till intravenös infusion, lösning	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
humant normalt immunglobulin 5 g, infusionsvätska, lösning, flaska	Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug)
humant normalt immunglobulin 6 g, injektionsvätska, lösning, flaska	Human immunoglobulin G 6 G powder for solution for injection vial
humant normalt immunglobulin 6 g, infusionsvätska, lösning, flaska	Human immunoglobulin G 6 G powder for solution for injection vial
humant normalt immunglobulin 750 mg, injektionsvätska, lösning, flaska	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)
Human papillomavirus group	Human papillomavirus
har avböjt HPV-test (humant papillomvirus)	Screening for Human papillomavirus declined (situation)
Human protein C 1000iu injection (pdr for recon)+solvent	Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug)
humant protein C, 1 000 IE, pulver och spädningsvätska för beredning av injektionsvätska	Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Human protein C 500iu injection (pdr for recon)+solvent	Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
humant protein C, 500 IE, pulver och spädningsvätska för beredning av injektionsvätska	Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
rekombinant humant koriongonadotropin alfa, 250 mikrogram, pulver för beredning av injektionslösning + spädningsvätska	Choriogonadotropin alfa only product in parenteral dose form
humant immunglobulin mot fästingburen encefalit, injektionsvätska, lösning, flaska 1 ml	Human tick borne encephalitis immunoglobulin only product in parenteral dose form
humant immunglobulin mot fästingburen encefalit, injektionsvätska, lösning, flaska 10 ml	Human tick borne encephalitis immunoglobulin only product in parenteral dose form
humant immunglobulin mot fästingburen encefalit, injektionsvätska, lösning, flaska 2 ml	Human tick borne encephalitis immunoglobulin only product in parenteral dose form
humant immunglobulin mot fästingburen encefalit, injektionsvätska, lösning, flaska 5 ml	Human tick borne encephalitis immunoglobulin only product in parenteral dose form
human vaccination	Active immunization
humant immunglobulin mot vaccinia 50 mg/ml, injektionsvätska, lösning, flaska 50 ml	Vaccinia human immune globulin 50 mg/mL solution for injection
miljö med hög luftfuktighet	Humid environment (finding)
biverkning av Humulin-insulin	Adverse reaction caused by human insulin (disorder)
Hyaline membrane disease	Respiratory distress syndrome in the newborn
Hyaluronidase 1500unt/10mL injection	Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
hyaluronidas 150 enheter/ml, injektionsvätska, lösning, flaska 10 ml	Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
hyaluronidas 150 enheter/ml, injektionsvätska, lösning, flaska 1 ml	Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
mola hydatidosa	Hydatidiform mole, benign (morphologic abnormality)
hydralazinhydroklorid 20 mg, pulver till injektionsvätska, injektionsflaska	Hydralazine hydrochloride 20 mg powder for solution for injection vial
medel mot tuberkulos innehållande hydrazid	Antituberculosis agent
biverkning av läkemedel mot tuberkulos innehållande hydrazid	Isoniazid adverse reaction
Hydrochlorothiazide + quinapril hydrochloride	Product containing hydrochlorothiazide and quinapril (medicinal product)
Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet	Hydrochlorothiazide 12.5 mg and quinapril (as quinapril hydrochloride) 10 mg oral tablet
Hydrochlorothiazide 25mg	Hydrochlorothiazide 25 mg oral tablet
hydrokortison 1 % + pramoxin 1 %, rektalskum	Hydrocortisone and pramocaine only product
hydrokortison 1 % + pramokain 1 % , skum, för användning som lavemang	Hydrocortisone and pramocaine only product
Hydrocortisone 100mg/60mL	Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
hydrokortison 100 mg/60 ml, lavemang	Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
hydrokortison 2 %, lotion för lokalt bruk	Hydrocortisone acetate 20 mg/mL cutaneous lotion
hydrokortisonacetat 1 %, ögondroppar	Hydrocortisone 10 mg/mL eye solution
hydrokortisonacetat 2,5 % kräm	Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
hydrokortisonacetat 1,5 % + neomycinsulfat 0,5 %, ögondroppar	Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution
hydrokortisoncypionat 10 mg/5 ml, suspension	Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)
Hydrocortisone/neomycin cream	Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream
Hydrolyase	Hydrolyase
hydromorfonhydroklorid 100 %, pulver	Hydromorphone only product
hydromorfonhydroklorid 12 mg, kapsel med modifierad frisättning	Product containing only hydromorphone in oral dose form (medicinal product form)
hydromorfonhydroklorid 12 mg, depåkapsel	Product containing only hydromorphone in oral dose form (medicinal product form)
hydromorfonhydroklorid 1 mg/ml, injektionsvätska, lösning, ampull	Hydromorphone hydrochloride 1 mg/mL solution for injection
hydromorfonhydroklorid 32 mg, kapsel med modifierad frisättning	Product containing only hydromorphone in oral dose form (medicinal product form)
hydromorfonhydroklorid 32 mg, depåkapsel	Product containing only hydromorphone in oral dose form (medicinal product form)
hydromorfonhydroklorid 4 mg/ml, injektionsvätska, lösning, ampull	Hydromorphone hydrochloride 4 mg/mL solution for injection
lanolin 4 % + zinkoxid 8 %, hudkräm	Lanolin and zinc oxide only product in cutaneous dose form
lanolin 4 % + zinkoxid 8 %	Lanolin and zinc oxide only product in cutaneous dose form
hydroxokobalamin 1mg/ml, injektionsvätska, lösning, ampull 1 ml	Product containing precisely hydroxocobalamin (as hydroxocobalamin acetate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
hydroxokobalamin 2,5 g, pulver till injektionsvätska, lösning, flaska	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
hydroxokobalamin 2,5 g, pulver till injektionsvätska, flaska + spädningsvätska	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
hydroxietylcellulosa 0,44 %, ögondroppar	Product containing only hyetellose (medicinal product)
hydroxietylcellulosa 0,44 %, ögondroppar för engångsbruk	Product containing only hyetellose (medicinal product)
hydroxipropylmetylcellulosa 0,32 %, ögondroppar	Hypromellose 3.2 mg/mL eye solution
hydroxipropylmetylcellulosa 0,32 %, ögondroppar för engångsbruk	Hypromellose 3.2 mg/mL eye solution
hydroxipropylmetylcellulosa 2 %, ögondroppar	Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug)
skopolaminbutylbromidallergi	Allergy to hyoscine
skopolaminhydrobromid 0,125 %, ögondroppar	Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution
skopolaminhydrobromid 0,25 %, ögondroppar	Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
skopolaminhydrobromid 0,5 %, ögondroppar	Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution
allergi mot skopolaminhydrobromid	Allergy to hyoscine
hyoscyaminsulfat 0,031 mg/ml	Hyoscyamine only product
hyoscyaminsulfat 0,125 mg/5 ml, elixir	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/5mL liquid	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/mL liquid	Hyoscyamine sulfate 25 microgram/mL oral solution

Start Previous Page 41 of 107 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)